يعرض 1 - 13 نتائج من 13 نتيجة بحث عن '"isoanticuerpos"', وقت الاستعلام: 0.41s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Report
  4. 4
  5. 5
  6. 6
    Academic Journal

    المساهمون: Peyvandi,F, Mannucci,PM, Santagostino,E, Mancuso,ME the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca’ Granda Ospedale Maggiore Policlinico, Italy. Peyvandi,F, Garagiola,I Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Italy. Zanon,E Milan, Clinica Medica II, Azienda Ospedaliera di Padova, Centro Emofilia, Padua. Italy. Mazzucconi,MG Ematologia, Unità Operativa Diagnostica Speciale e Terapia delle Malattie dell’Emostasi e della Trombosi, Università Sapienza, Policlinico Umberto I, Rome, Italy. El-Beshlawy,A The Pediatric Hematology Department, Cairo University Pediatric Hospital, Cairo. Elalfy,M Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo. Ramanan,V Jehangir Clinical Development Center, Department of Hematology, Jehangir Hospital Premises, India. , Apte,S Sahyadri Speciality Hospita, l India. Hanagavadi,S Pune, Jagadguru Jayadeva Murugarajendra Medical College, Davangere, India. Baradajaran,P Center for Blood Disorders, Chennai, India. Manglani,MV Lokmanya Tilak Municipal Medical College and General Hospital, Mumbai, India. Ross,C St. John’s Medical College Hospital, Bangalore India. Seth,T India Institute of Medical Sciences, Department of Hematology, India. Sachdeva,A Pediatric Hematology Oncology and Bone Marrow Transplantation, Institute for Child Health, Sir Ganga Ram Hospital, India. Nayak,DM New Delhi, Melaka-Manipal Medical College, Manipal University, Manipal, India. Thomas,M Kerala Institute of Medical Science, Trivandrum, India. Eshghi,P The Congenital Pediatric Hematologic Disorders Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Karimi,M Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Young,G Children’s Hospital Los Angeles, Los Angeles,California. Ewing,NP City of Hope National Medical Center, Duarte, California. Sandoval Gonzalez, AC Hospital de Especialidades Unidad Médica de Alta Especialidad, Instituto Mexicano del Seguro Social, Monterrey, Mexico. Paredes Aguilera,R Instituto Nacional de Pediatria, Mexico City, Mexico. Mahlangu,JN Faculty of Health Sciences, School of Pathology, University of the Witwatersrand, National Health Laboratory Service and Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg. Bonanad Boix,S Hospital Universitario La Fe, Unidad Coagulopatias Congenitas, Valencia, Spain. Perez Garrido, R Hospital Universitario Virgen del Rocío, Unidad de Hemofilia, Seville, Spain. Palomo Bravo,A Hospital Regional Universitario Carlos Haya, Malaga, Spain. Cerqueira,M Centro de Pesquisa Clinica Hemorio–Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti, Rio de Janeiro, Brazil. Prezotti,A Centro de Hematologia e Hemoterapia do Espírito Santo, Vitoria, Brazil. Male,C Medizinische Universität Wien, Department of Pediatrics, Vienna, Austria. Schmitt,K Department of Pediatric and Adolescent Medicine, Kepler University Clinic, Linz, Austria. Owaidah,T King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. Soto Arellano,V Centro de Hemofílicos del Hospital de Niños Dr. Roberto del Río, Chile. Marzouka,E Hospital de Niños Dr. Luis Calvo Mackenna, Centro Hemofílico, Santiago, Chile. Kobrinsky, NL Sanford Roger Maris Cancer Center, Fargo, ND. Majundar,S University of Mississippi Medical Center, Division of Pediatric Hematology–Oncology, Jackson. Simpson,M Rush Hemophilia and Thrombophilia Center, Rush University Medical Center, Chicago. Antmen,B Cukurova Universitesi, Tip Fakultesi Pediatrik Hematoloji Bilim Dali, Adana, Turkey. Kabakli,K Ege Universitesi Tip Fakultesi Cocuk Sagligi ve Hastalikari Anabilim Dali, Pediatrik Hematoloji Bilim Dali, Turkey. Zulfikar,B Istanbul Universitesi Cerrahpasa Tip Fakultesi, Pediatrik Hematoloji Bilim Dali, Istanbul,Turkey. Manco-Johnson,MJ Hemophilia and Thrombosis Center, University of Colorado Denver, Aurora. Martinez,M Hospital de Niños Sor María Ludovica La Plata, Servicio de Hematología, Buenos Aires. Neme,D Fundación de la Hemofilia, Buenos Aires. Wicklund,BM Children’s Mercy Hospital, Kansas City, MO, The Netherlands. Rosendaal,FR he Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.

    وصف الملف: application/pdf

    Relation: Peyvandi F, Mannucci PM, Garagiola I, El-Beshlawy A, Elalfy M, Ramanan V, et al. A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A. N Engl J Med. 2016; 374(21):2054-64; http://hdl.handle.net/10668/2671

  7. 7
    Academic Journal

    المصدر: Dominio de las Ciencias, ISSN 2477-8818, Vol. 7, Nº. 6, 2021 (Ejemplar dedicado a: OCTUBRE 2021), pags. 1225-1240

    وصف الملف: application/pdf

    Relation: https://dialnet.unirioja.es/servlet/oaiart?codigo=8383803; (Revista) ISSN 2477-8818

  8. 8
    Academic Journal
  9. 9
    Academic Journal

    المصدر: Biomedica; Vol. 40 No. 3 (2020); 479-486 ; Biomédica; Vol. 40 Núm. 3 (2020); 479-486 ; 2590-7379 ; 0120-4157

    وصف الملف: application/pdf; text/xml

    Relation: https://revistabiomedica.org/index.php/biomedica/article/view/5092/4502; https://revistabiomedica.org/index.php/biomedica/article/view/5092/4707; Sá H, Leal R, Rosa MS. Renal transplant immunology in the last 20 years: A revolution towards graft and patient survival improvement. Int Rev Immunol. 2017;36:182-203. https://doi.org/10.1080/08830185.2016.1225300; Locke JE, Zachary AA, Warren DS, Segev DL, Houp JA, Montgomery RA, et al. Proinflammatory events are associated with significant increases in breadth and strength of HLA-specific antibody. Am J Transplant. 2009;9:2136-9. https://doi.org/10.1111/j.1600-6143.2009.02764.x; Haas M, Loupy A, Lefaucheur C, Roufosse C, Glotz D, Seron D, et al. The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials. Am J Transplant. 2018;18:293-307. https://doi.org/10.1111/ajt.14625; Djamali A, Kaufman DB, Ellis TM, Zhong W, Matas A, Samaniego M. Diagnosis and management of antibody-mediated rejection: Current status and novel approaches. Am J Transplant. 2014;14:255-71. https://doi.org/10.1111/ajt.12589; Gosset C, Viglietti D, Rabant M, Vérine J, Aubert O, Glotz D, et al. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis. Kidney Int. 2017;92:729-42. https://doi.org/10.1016/j.kint.2017.03.033; Cioni M, Nocera A, Innocente A, Tagliamacco A, Trivelli A, Basso S, et al. De novo donorspecific HLA antibodies developing early or late after transplant are associated with the same risk of graft damage and loss in nonsensitized kidney recipients. J Immunol Res. 2017;2017:1747030. https://doi.org/10.1155/2017/1747030; Mengel M, Sis B, Haas M, Colvin RB, Halloran PF, Racusen LC, et al. Banff 2011 meeting report: New concepts in antibody-mediated rejection. Am J Transplant. 2012;12:563-70. https://doi.org/10.1111/j.1600-6143.2011.03926.x; Colvin RB, Smith RN. Antibody-mediated organ-allograft rejection. Nat Rev Immunol. 2005;5:807-17. https://doi.org/10.1038/nri1702; Wiebe C, Gibson IW, Blydt-Hansen TD, Karpinski M, Ho J, Storsley LJ, et al. Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am J Transplant. 2012;12:1157-67. https://doi.org/10.1111/j.1600-6143.2012.04013.x; Sis B, Halloran PF. Endothelial transcripts uncover a previously unknown phenotype: C4dnegative antibody-mediated rejection. Curr Opin Organ Transplant. 2010;15:42-8. https://doi.org/10.1097/MOT.0b013e3283352a50; Wiebe C, Gibson IW, Blydt-Hansen TD, Pochinco D, Birk PE, Ho J, et al. Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donorspecific antibody. Am J Transplant. 2015;15:2921-30. https://doi.org/10.1111/ajt.13347; Hidalgo LG, Campbell PM, Sis B, Einecke G, Mengel M, Chang J, et al. De novo donorspecific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant. 2009;9:2532-41. https://doi.org/10.1111/j.1600-6143.2009.02800.x; Racusen LC, Haas M. Antibody-mediated rejection in renal allografts: Lessons from pathology. Clin J Am Soc Nephrol. 2006;1:415-20. https://doi.org/10.2215/CJN.01881105; Haas M, Sis B, Racusen LC, Solez K, Glotz D, Colvin RB, et al. Banff 2013 meeting report: Inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant. 2014;14: 272-83. https://doi.org/10.1111/ajt.12590; Tait BD, Süsal C, Gebel HM, Nickerson PW, Zachary AA, Claas FHJ, et al. Consensus guidelines on the testing and clinical management issues associated with HLA and Non-HLA antibodies in transplantation. Transplantation. 2013;95:19-47. https://doi.org/10.1097/TP.0b013e31827a19cc; Bestard O, Cravedi P. Monitoring alloimmune response in kidney transplantation. J Nephrol. 2017;30:187-200. https://doi.org/10.1007/s40620-016-0320-7; Billen EVA, Christiaans MHL, Lee J, van den Berg-Loonen EM. Donor-directed HLA antibodies before and after transplantectomy detected by the luminex single antigen assay. Transplantation. 2009;87:563-9. https://doi.org/10.1097/TP.0b013e3181949e37; Huber L, Lachmann N, Niemann M, Naik M, Liefeldt L, Glander P, et al. Pretransplant virtual PRA and long-term outcomes of kidney transplant recipients. Transpl Int. 2015;28:710-9. https://doi.org/10.1111/tri.12533; Ercilla MG, Martorell J. Estudio inmunológico de la pareja donante-receptor. Nefrología. 2010;30:60-70. https://doi.org/10.3265/Nefrologia.pre2010.Nov.10692; Tambur AR, Campbell P, Claas FH, Feng S, Gebel HM, Jackson AM, et al. Sensitization in transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report. Am J Transplant. 2018;18:1604-14. https://doi.org/10.1111/ajt.14752; Crespo E, Bestard O. Biomarkers to assess donor-reactive T-cell responses in kidney transplant patients. Clin Biochem. 2016;49:329-37. https://doi.org/10.1016/j.clinbiochem.2015.08.010; Grenzi PC, Campos ÉF, Silva HT, Felipe CR, Franco MF, Soares MF, et al. Post-transplant soluble CD30 levels are associated with early subclinical rejection in kidney transplantation. Transpl Immunol. 2015;32:61-5. https://doi.org/10.1016/j.trim.2015.02.004; Süsal C, Fichtner A, Tönshoff B, Mehrabi A, Zeier M, Morath C. Clinical relevance of HLA antibodies in kidney transplantation: Recent data from the Heidelberg Transplant Center and the Collaborative Transplant Study. J Immunol Res. 2017;2017:5619402. https://doi.org/10.1155/2017/5619402; Aubert O, Loupy A, Hidalgo L, van Huyen JPD, Higgins S, Viglietti D, et al. Antibody-mediated rejection due to preexisting versus de novo donor-specific antibodies in kidney allograft recipients. J Am Soc Nephrol. 2017;28:1912-23. https://doi.org/10.1681/ASN.2016070797; Mehra NK, Baranwal AK. Clinical and immunological relevance of antibodies in solid organ transplantation. Int J Immunogenet. 2016;43:351-68. https://doi.org/10.1111/iji.12294; Morath C, Opelz G, Zeier M, Süsal C. Clinical relevance of HLA antibody monitoring after kidney transplantation. J Immunol Res. 2014;2014:845040. https://doi.org/10.1155/2014/845040; Halloran PF, De Freitas DG, Einecke G, Famulski KS, Hidalgo LG, Mengel M, et al. The molecular phenotype of kidney transplants: Personal viewpoint. Am J Transplant. 2010;10:2215-22. https://doi.org/10.1111/j.1600-6143.2010.03267.x; Roedder S, Sigdel T, Salomonis N, Hsieh S, Dai H, Bestard O, et al. The kSORT assay to detect renal transplant patients at high risk for acute rejection: Results of the multicenter AART Study. PLoS Med. 2014;11. https://doi.org/10.1371/journal.pmed.1001759; Zhang Q, Reed EF. The importance of non-HLA antibodies in transplantation. Nat Rev Nephrol. 2016;12:484-95. https://doi.org/10.1038/nrneph.2016.88; Pearl MH, Zhang Q, Palma-Diaz MF, Grotts J, Rossetti M, Elashoff D, et al. Angiotensin II type 1 receptor antibodies are associated with inflammatory cytokines and poor clinical outcomes in pediatric kidney transplantation. Kidney Int. 2018;93:260-9. https://doi.org/10.1016/j.kint.2017.06.034; https://revistabiomedica.org/index.php/biomedica/article/view/5092

  10. 10
  11. 11
  12. 12

    المساهمون: Çukurova Üniversitesi, Ege Üniversitesi, [Peyvandi,F, Mannucci,PM, Santagostino,E, Mancuso,ME] the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca’ Granda Ospedale Maggiore Policlinico, Italy. [Peyvandi,F, Garagiola,I] Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Italy. [Zanon,E] Milan, Clinica Medica II, Azienda Ospedaliera di Padova, Centro Emofilia, Padua. Italy. [Mazzucconi,MG] Ematologia, Unità Operativa Diagnostica Speciale e Terapia delle Malattie dell’Emostasi e della Trombosi, Università Sapienza, Policlinico Umberto I, Rome, Italy. [El-Beshlawy,A] The Pediatric Hematology Department, Cairo University Pediatric Hospital, Cairo. [Elalfy,M] Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo. [Ramanan,V] Jehangir Clinical Development Center, Department of Hematology, Jehangir Hospital Premises, India. , [Apte,S] Sahyadri Speciality Hospita, l India. [Hanagavadi,S] Pune, Jagadguru Jayadeva Murugarajendra Medical College, Davangere, India. [Baradajaran,P] Center for Blood Disorders, Chennai, India. [Manglani,MV] Lokmanya Tilak Municipal Medical College and General Hospital, Mumbai, India. [Ross,C] St. John’s Medical College Hospital, Bangalore India. [Seth,T] India Institute of Medical Sciences, Department of Hematology, India. [Sachdeva,A] Pediatric Hematology Oncology and Bone Marrow Transplantation, Institute for Child Health, Sir Ganga Ram Hospital, India. [Nayak,DM] New Delhi, Melaka-Manipal Medical College, Manipal University, Manipal, India. [Thomas,M] Kerala Institute of Medical Science, Trivandrum, India. [Eshghi,P] The Congenital Pediatric Hematologic Disorders Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. [Karimi,M] Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. [Young,G] Children’s Hospital Los Angeles, Los Angeles,California. [Ewing,NP] City of Hope National Medical Center, Duarte, California. [Sandoval Gonzalez, AC] Hospital de Especialidades Unidad Médica de Alta Especialidad, Instituto Mexicano del Seguro Social, Monterrey, Mexico. [Paredes Aguilera,R] Instituto Nacional de Pediatria, Mexico City, Mexico. [Mahlangu,JN] Faculty of Health Sciences, School of Pathology, University of the Witwatersrand, National Health Laboratory Service and Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg.[Bonanad Boix,S] Hospital Universitario La Fe, Unidad Coagulopatias Congenitas, Valencia, Spain. [Perez Garrido, R] Hospital Universitario Virgen del Rocío, Unidad de Hemofilia, Seville, Spain. [Palomo Bravo,A] Hospital Regional Universitario Carlos Haya, Malaga, Spain. [Cerqueira,M] Centro de Pesquisa Clinica Hemorio–Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti, Rio de Janeiro, Brazil. [Prezotti,A] Centro de Hematologia e Hemoterapia do Espírito Santo, Vitoria, Brazil. [Male,C] Medizinische Universität Wien, Department of Pediatrics, Vienna, Austria. [Schmitt,K] Department of Pediatric and Adolescent Medicine, Kepler University Clinic, Linz, Austria. [Owaidah,T] King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia. [Soto Arellano,V] Centro de Hemofílicos del Hospital de Niños Dr. Roberto del Río, Chile. [Marzouka,E] Hospital de Niños Dr. Luis Calvo Mackenna, Centro Hemofílico, Santiago, Chile. [Kobrinsky, NL] Sanford Roger Maris Cancer Center, Fargo, ND. [Majundar,S] University of Mississippi Medical Center, Division of Pediatric Hematology–Oncology, Jackson. [Simpson,M] Rush Hemophilia and Thrombophilia Center, Rush University Medical Center, Chicago. [Antmen,B] Cukurova Universitesi, Tip Fakultesi Pediatrik Hematoloji Bilim Dali, Adana, Turkey. [Kabakli,K] Ege Universitesi Tip Fakultesi Cocuk Sagligi ve Hastalikari Anabilim Dali, Pediatrik Hematoloji Bilim Dali, Turkey. [Zulfikar,B] Istanbul Universitesi Cerrahpasa Tip Fakultesi, Pediatrik Hematoloji Bilim Dali, Istanbul,Turkey. [Manco-Johnson,MJ] Hemophilia and Thrombosis Center, University of Colorado Denver, Aurora. [Martinez,M] Hospital de Niños Sor María Ludovica La Plata, Servicio de Hematología, Buenos Aires. [Neme,D] Fundación de la Hemofilia, Buenos Aires.[Wicklund,BM] Children’s Mercy Hospital, Kansas City, MO, The Netherlands. [Rosendaal,FR] he Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.

    المصدر: New England Journal of Medicine, 374(21), 2054-2064
    NEW ENGLAND JOURNAL OF MEDICINE
    r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
    instname

    مصطلحات موضوعية: Male, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Models, Statistical::Proportional Hazards Models [Medical Subject Headings], Named Groups::Persons::Age Groups::Adult::Middle Aged [Medical Subject Headings], Adulto joven, 030204 cardiovascular system & hematology, Gastroenterology, law.invention, Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], 0302 clinical medicine, Randomized controlled trial, Isoantibodies, law, Hemorragia, hemic and lymphatic diseases, Medicine, Child, Masculino, Adolescente, Named Groups::Persons::Age Groups::Child::Child, Preschool [Medical Subject Headings], biology, Adulto, Incidence, Hemofilia A, General Medicine, Middle Aged, Modelos de riesgos proporcionales, Humanos, Diseases::Hemic and Lymphatic Diseases::Hematologic Diseases::Hemorrhagic Disorders::Hemophilia A [Medical Subject Headings], Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Administration Routes::Injections::Injections, Subcutaneous [Medical Subject Headings], Child, Preschool, Niño, Named Groups::Persons::Age Groups::Adolescent [Medical Subject Headings], Drug Therapy, Combination, Named Groups::Persons::Age Groups::Infant [Medical Subject Headings], Antibody, Incidencia, Niño preescolar, Adult, medicine.medical_specialty, Randomization, Adolescent, Named Groups::Persons::Age Groups::Adult::Young Adult [Medical Subject Headings], Injections, Subcutaneous, Anciano, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Therapy, Combination [Medical Subject Headings], Check Tags::Male [Medical Subject Headings], Hemorrhage, Hemophilia A, Isoanticuerpos, Bethesda unit, Anticuerpos neutralizantes, Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Hemorrhage [Medical Subject Headings], Young Adult, 03 medical and health sciences, Pharmacotherapy, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Data Collection::Vital Statistics::Morbidity::Incidence [Medical Subject Headings], Von Willebrand factor, Internal medicine, von Willebrand Factor, Named Groups::Persons::Age Groups::Adult [Medical Subject Headings], Humans, Factor de von Willebrand, Named Groups::Persons::Age Groups::Adult::Aged [Medical Subject Headings], Named Groups::Persons::Age Groups::Child [Medical Subject Headings], Aged, Proportional Hazards Models, Emicizumab, Mediana edad, Factor VIII, Dose-Response Relationship, Drug, business.industry, Phenomena and Processes::Physiological Phenomena::Pharmacological Phenomena::Dose-Response Relationship, Drug [Medical Subject Headings], Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Globulins::Serum Globulins::Immunoglobulins::Antibodies::Isoantibodies [Medical Subject Headings], Infant, Inyecciones subcutáneas, Lactante, Antibodies, Neutralizing, Relación dosis-respuesta de medicamentos, Chemicals and Drugs::Biological Factors::Blood Coagulation Factors::von Willebrand Factor [Medical Subject Headings], Surgery, Farmacoterapia combinada, Chemicals and Drugs::Biological Factors::Blood Coagulation Factors::Factor VIII [Medical Subject Headings], biology.protein, Chemicals and Drugs::Amino Acids, Peptides, and Proteins::Proteins::Globulins::Serum Globulins::Immunoglobulins::Antibodies::Antibodies, Neutralizing [Medical Subject Headings], business, 030215 immunology

    وصف الملف: application/pdf

  13. 13